www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

USEUROPEAFRICAASIA 中文雙語Fran?ais
Business
Home / Business / Companies

US company partners with Chinese firm to tackle rare disease

Xinhua | Updated: 2017-09-27 09:13

SHANGHAI — Staff with US company Amicus Therapeutics regularly travel to Shanghai to work out how to develop a new drug to treat Pompe disease, a rare muscle disorder.

John Crowley, chief executive of the company, led the recent trip to its Chinese partner WuXi Biologics, based in Shanghai.

Crowley said the new drug was expected to reduce the side effects of existing enzyme replacement therapy.

The disorder prevents the human body from making enough of an enzyme used by heart and muscle cells to convert a form of sugar called glycogen into energy. When glycogen builds up in these cells it can lead to swelling of the heart, disability and early death.

Crowley has led a personal struggle to save his daughter and son, who are afflicted with Pompe disease.

Crowley said his company chose WuXi Biologics as its contract manufacturer, even though some company board members questioned the decision, doubting such high-quality drugs could be made by a Chinese firm.

Currently, the drug is in stage two of clinical trials, and around 20 patients are being tested with the drug in the United States.

By the middle of next year, it is expected to enter stage three, and be applied to more patients for tests, Crowley said.

Chinese patients are expected to be included in the trials, he said. Gao Ru, founder of a Chinese Pompe patient association, said the cooperation would benefit Chinese patients. She estimated there are about 35,000 Pompe patients in China.

Gao said she managed to contact about 100 of them, 80 percent of whom were adults, and 20 percent babies.

For an adult patient, the annual medical cost is around 3 million yuan (about $460,000).

"I hope the cost for the prescription can be reduced," she said.

Crowley helped founded Novazyme, a company working on Pompe disease treatment. The company was was acquired by Genzyme in 2011. Now Paris-based Sanofi SA owns the drugs. He later founded Amicus Therapeutics to develop therapy for rare disease including Pompe.

"If you compare ordinary drugs to a bicycle, bio-medicine is like a plane. It is very difficult to make," said Chen Zhisheng, CEO of WuXi Biologics.

"The new generation drugs to treat Pompe diseases needs to be very accurate in dealing with the disorder. Both our companies will be committed to the development of the drugs until they are put on the market and bring benefits to patients," Chen said.

Most Viewed in 24 Hours
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 九九综合九九综合 | 手机看片福利永久 | 2021国产精品自在拍在线播放 | 免费观看成人久久网免费观看 | 欧美一区二区三区视频 | 欧美成人免费高清二区三区 | 美女被爆免费视频软件 | 午夜看片a福利在线 | 久久久这里只有精品免费 | 欧美日韩一级黄色片 | 久久成人性色生活片 | 欧美性高清视频免费看www | 美国一级毛片免费看成人 | 久久性感视频 | 99爱在线观看精品视频 | 日本b站一卡二卡乱码入口 日本s色大片在线观看 | 亚欧成人毛片一区二区三区四区 | 理论片免费午夜 | 欧美一级特黄aa大片 | 久久精品免费观看视频 | 亚洲欧美一区二区三区久久 | 免费国产成人α片 | 免费一区二区三区久久 | 日韩亚洲精品不卡在线 | av狼论坛 | 久久国产中文字幕 | www.毛片com | 欧美午夜不卡在线观看最新 | 国产一级高清 | 加勒比一区二区 | 国产午夜毛片v一区二区三区 | 毛片a区| 成人精品国产亚洲 | 欧美一级特黄aa大片在线观看免费 | 午夜主播福利视频在线观看 | 免费香蕉成视频成人网 | 美国三级在线观看 | 亚洲第一黄色网 | 免费播放欧美毛片 | 一本三道a无线码一区v | 亚洲天堂伊人 |